Your browser doesn't support javascript.
loading
Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation.
Yamamoto, Saori; Nagasawa, Tasuku; Sugimura, Koichiro; Kanno, Atsuhiro; Tatebe, Shunsuke; Aoki, Tatsuo; Sato, Haruka; Kozu, Katsuya; Konno, Ryo; Nochioka, Kotaro; Satoh, Kimio; Shimokawa, Hiroaki.
Afiliación
  • Yamamoto S; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.
  • Nagasawa T; Department of Nephrology, Japanese Red Cross Ishinomaki Hospital, Japan.
  • Sugimura K; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.
  • Kanno A; Department of Nephrology, Japan Community Health Care Organization, Japan.
  • Tatebe S; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.
  • Aoki T; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.
  • Sato H; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.
  • Kozu K; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.
  • Konno R; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.
  • Nochioka K; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.
  • Satoh K; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.
  • Shimokawa H; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.
Intern Med ; 58(4): 603-607, 2019 Feb 15.
Article en En | MEDLINE | ID: mdl-30333391
Anderson-Fabry disease (AFD) is a rare X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A (α-GAL A). We herein report 10 cases of AFD in 5 families (3 men and 7 women) that were found to have a specific common mutation in R301Q [G-to-A transition in exon 6 (codon 301) resulting in the replacement of a glutamine with an arginine residue]. We evaluated their clinical characteristics, residual enzymatic activity, and plasma concentrations of globotriaosylsphingosine (Lyso-Gb3). Although all 10 cases had cardiac and renal manifestations in common, their clinical manifestations were markedly divergent despite the same genetic abnormality.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esfingolípidos / Glucolípidos / Enfermedad de Fabry / Alfa-Galactosidasa / Mutación Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esfingolípidos / Glucolípidos / Enfermedad de Fabry / Alfa-Galactosidasa / Mutación Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2019 Tipo del documento: Article País de afiliación: Japón